Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Corcept Therapeutics Incorporated (CORT) vs Bio-Techne Corp (TECH)

Corcept Therapeutics Incorporated and Bio-Techne Corp are both Biotechnology companies. Corcept Therapeutics Incorporated is the larger, with a market value of $12.9B against $11.4B — 1.1× the size. Bio-Techne Corp trades at the lower P/E: 62.1× against 223×. Corcept Therapeutics Incorporated grew revenue faster over the last twelve months: 16.0% against −0.38%. Bio-Techne Corp has the higher net margin (15.0% vs 6.53%) and the higher return on invested capital (7.70% vs 1.01%). Both pay a dividend; Bio-Techne Corp yields more (0.37% vs 0.31%). Across the 23 metrics below, Bio-Techne Corp leads on 18 and Corcept Therapeutics Incorporated on 5.

Valuation

Metric CORT TECH Biotechnology median
P/E 223.27 62.06 7.88
P/S 14.73 9.32 11.47
P/B 17.33 5.37 2.52
Price to free cash flow 114.42 43.02 21.16
EV/EBITDA 3,205.62 32.27 0.74
EV/Sales 14.36 9.28 10.73
Earnings yield 0.45% 1.61% (28.84%)
Free cash flow yield 0.87% 2.32% (23.03%)

Profitability

Metric CORT TECH Biotechnology median
Gross margin 98.30% 65.77% 65.16%
Operating margin 0.77% 20.73% 0.00%
Net margin 6.53% 14.97% 0.00%
Free cash flow margin 12.87% 21.66% 0.00%
Return on equity 8.08% 9.03% (57.72%)
Return on assets 6.41% 7.07% (49.22%)
Return on invested capital 1.01% 7.70% 0.00%

Growth

Metric CORT TECH Biotechnology median
Revenue growth (TTM) 16.02% (0.38%) 5.64%
EPS growth (last fiscal year) (33.33%) 152.17% —
Revenue growth, 5-year CAGR 16.56% 5.47% 8.40%
Net income growth, 5-year CAGR (1.52%) 5.31% 0.00%

Health

Metric CORT TECH Biotechnology median
Debt to equity 0.00 0.09 0.00
Current ratio 2.86 4.55 4.73
Net debt to EBITDA (8.83) (0.19) 0.96

Dividend

Metric CORT TECH Biotechnology median
Dividend yield 0.31% 0.37% 2.10%
Payout ratio 0.00 0.18 0.00

Size

Metric CORT TECH Biotechnology median
Market cap 12.87b 11.38b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack